Page last updated: 2024-09-05
lignin and epiyangambin
lignin has been researched along with epiyangambin in 1 studies
Compound Research Comparison
| Studies (lignin) | Trials (lignin) | Recent Studies (post-2010) (lignin) | Studies (epiyangambin) | Trials (epiyangambin) | Recent Studies (post-2010) (epiyangambin) |
|---|---|---|---|---|---|
| 13,390 | 26 | 9,534 | 18 | 0 | 4 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bozza, PT; Castro-Faria-Neto, HC; Cordeiro, RS; Cruz, HN; de Queiroz-Paulo, M; Kaplan, MA; Martins, MA; Silva, PM | 1 |
Other Studies
1 other study(ies) available for lignin and epiyangambin
| Article | Year |
|---|---|
Pharmacological profile of epiyangambin: a furofuran lignan with PAF antagonist activity.
Topics: Animals; Furans; Lignans; Lignin; Male; Molecular Structure; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Wistar; Thrombocytopenia | 1993 |